Industry Steps Up To Help India Through Second Wave
Zydus Cadila, Natco, Strides And Dr Reddy’s Work On COVID Treatments
As India sees a consistent rise in daily cases and deaths due to COVID-19, the off-patent industry is stepping up to make drugs affordable and available. Zydus Cadila is seeking approval for virafin, while Natco has applied for molnupiravir approval. Vaccine production and availability has also come under focus.
